Keyphrases
Tumor
100%
Glioblastoma
100%
Vorinostat
100%
Response Prediction
100%
Early Prediction
100%
1H-MRS
100%
Histone Deacetylase Inhibitor (HDACi)
66%
N-acetylaspartate
66%
Inositol
66%
Imaging Methods
33%
Drug Delivery
33%
Size Reduction
33%
Adjuvant Therapy
33%
Metabolic Biomarkers
33%
Potent Inhibitor
33%
Tumor Suppressor Gene
33%
Potential Biomarkers
33%
Epigenetic Modification
33%
Tumor Therapy
33%
Therapeutic Response
33%
Oncologists
33%
Oncogenesis
33%
Glioma
33%
Brain Tissue
33%
Tumor Size
33%
Invasive Procedures
33%
Non-invasive Method
33%
Primary Brain Tumor
33%
Lactate Level
33%
Surgical Therapy
33%
Drug Efficacy
33%
Suberoylanilide Hydroxamic Acid
33%
Brain Tumor
33%
Histone Acetylation
33%
Orally Active
33%
Early Response
33%
Normal Brain Tissues
33%
Tumor Viability
33%
Orthotopic Model
33%
Cytostasis
33%
Histological Evaluation
33%
Histone Deacetylase Activity
33%
Mood Depression
33%
Redifferentiation
33%
Medicine and Dentistry
Vorinostat
100%
Ganglioglioma
100%
Neoplasm
50%
Biological Marker
40%
Glioblastoma
30%
Proton Nuclear Magnetic Resonance
30%
Metabolite
20%
Brain Tissue
20%
Inositol
20%
Carcinogenesis
10%
Adjuvant Therapy
10%
Lactic Acid
10%
Tumor Suppressor Gene
10%
Histone Deacetylase
10%
Cancer Therapy
10%
Oncologist
10%
Non Invasive Procedure
10%
Histone
10%
Histone Deacetylase Inhibitor
10%
Invasive Procedure
10%
Alanine
10%
Treatment Response
10%
Epigenetic Modification
10%
Surgery
10%
Deacetylation
10%
Neuroscience
Inositol
100%
Alanine
50%
Carcinogenesis
50%
Histone
50%
Epigenetic Modification
50%
Hydroxamic Acid
50%
Histone Deacetylase
50%
Histone Deacetylase Inhibitor
50%
Tumor Suppressor Gene
50%
Cytostasis
50%
Pharmacology, Toxicology and Pharmaceutical Science
Vorinostat
100%
Neoplasm
60%
Biological Marker
40%
Glioblastoma
30%
Inositol
20%
Intracranial Tumor
20%
Carcinogenesis
10%
Lactic Acid
10%
Histone Deacetylase
10%
Alanine
10%
Histone
10%
Histone Deacetylase Inhibitor
10%
Tumor Suppressor Protein
10%